Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

NCT02071329 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A

Interventions

DRUG: Vaccine FP-01.1
DRUG: Placebo
OTHER: Virus Challenge

Sponsor

Immune Targeting Systems Ltd